Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03285152 · ClinicalTrials.gov registry record · NA
A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients
A NA study of Endometrial Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 19
- Enrollment target
- 8
- Study locations
NCT03285152: Active NA study of Endometrial Cancer, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03285152 is a NA study of Endometrial Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 19 participants, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (96% lower). The trial reports 8 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03285152, a NA study of Endometrial Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to test any good and bad effects of an experimental diet, called a ketogenic diet, in endometrial cancer. A ketogenic diet is one that is very low in carbohydrates (simple and complex sugars). The goal of this diet is for the body to go into a state of ketosis. Ketosis is when the body does not have enough sugar for energy so it burns stored fats which create acids called ketones, which can be used for energy. Researchers hope to learn whether or not a ketogenic diet is well-tolerated and safe to eat before surgery in endometrial cancer patients.
Conditions Studied
Interventions
- OTHER Ketogenic Diet (KD)
- OTHER Standard Diet (SD)
Study Locations (8)
New York
- Memorial Sloan Kettering Cancer Center @ Commack (Consent and Follow up) - Commack
- Memorial Sloan Kettering Westchester (Consent & Follow Up) - Harrison
- New York Weill Cornell Cancer Center at Cornell University - New York
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent and Follow-up) - Rockville Centre
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent and Follow up) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent and follow-up only) - Middletown
- Memorial Sloan Kettering Bergen (Consent and Follow up) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-02-19 |
| Est. Completion | 2026-08-11 |
| Phase | NA |
What the registry record for NCT03285152 still lists
NCT03285152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 524-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Endometrial Cancer appearing as the primary indexed condition, and to 2 interventions - of which Ketogenic Diet (KD) is the first listed.
NCT03285152 lists 8 locations in 2 states (New York, New Jersey).
Frequently Asked Questions
What is clinical trial NCT03285152 about?
NCT03285152 is a clinical study titled "A Study of Ketogenic Diet in Newly Diagnosed Overweight or Obese Endometrial Cancer Patients". The purpose of this study is to test any good and bad effects of an experimental diet, called a ketogenic diet, in endometrial cancer. A ketogenic diet is one that is very low in carbohydrates (simple and complex sugars). The goal of this diet is for the body to go into a state of ketosis. Ketosis i...
What is the current status of trial NCT03285152?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2018-02-19. Estimated completion is 2026-08-11.
What conditions does trial NCT03285152 study?
This clinical trial studies the following conditions: Endometrial Cancer.
What interventions are being tested in trial NCT03285152?
The interventions under investigation include: Ketogenic Diet (KD) (OTHER), Standard Diet (SD) (OTHER).
Who is sponsoring clinical trial NCT03285152?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03285152 being conducted?
This trial has 8 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03285152's enrollment target sits among peer trials
19 171st of 181 higher than 11 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI